within Pharmacolibrary.Drugs.N_NervousSystem.N02C_AntimigrainePreparations.N02CC51_SumatriptanAndNaproxen;
model SumatriptanAndNaproxen 
   extends Pharmacolibrary.Drugs.ATC.N.N02CC51;

  annotation(Documentation(
    info ="<html><body><p>Sumatriptan and naproxen is a fixed-dose combination medication used for the acute treatment of migraine attacks, with or without aura, in adults. Sumatriptan is a selective 5-HT1B/1D receptor agonist causing cranial vessel constriction and inhibition of neuropeptide release, while naproxen is a nonsteroidal anti-inflammatory drug (NSAID) that reduces inflammation and pain. The combination is FDA-approved and widely used in clinical practice.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters for sumatriptan and naproxen fixed combination, in healthy adult subjects, following oral administration.</p><h4>References</h4><ol><li><p>Syed, YY (2016). Sumatriptan/Naproxen Sodium: A Review in Migraine. <i>Drugs</i> 76(1) 111–121. DOI:<a href=&quot;https://doi.org/10.1007/s40265-015-0521-8&quot;>10.1007/s40265-015-0521-8</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/26628293/&quot;>https://pubmed.ncbi.nlm.nih.gov/26628293</a></p></li><li><p>Berges, A, et al., &amp; McDonald, SA (2010). Pharmacokinetics and tolerability of sumatriptan after single-dose administration of a fixed-dose combination tablet of sumatriptan/naproxen sodium 85/500 mg followed two hours later by subcutaneous sumatriptan 4- or 6-mg injection: a randomized, open-label, three-period crossover study in healthy volunteers. <i>Clinical therapeutics</i> 32(6) 1165–1177. DOI:<a href=&quot;https://doi.org/10.1016/j.clinthera.2010.06.014&quot;>10.1016/j.clinthera.2010.06.014</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/20637969/&quot;>https://pubmed.ncbi.nlm.nih.gov/20637969</a></p></li><li><p>Haberer, LJ, et al., &amp; McDonald, SA (2010). Distinct pharmacokinetic profile and safety of a fixed-dose tablet of sumatriptan and naproxen sodium for the acute treatment of migraine. <i>Headache</i> 50(3) 357–373. DOI:<a href=&quot;https://doi.org/10.1111/j.1526-4610.2009.01606.x&quot;>10.1111/j.1526-4610.2009.01606.x</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/20132340/&quot;>https://pubmed.ncbi.nlm.nih.gov/20132340</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>",
    experiment(StartTime = 0, StopTime = 86400, Tolerance = 1e-09, Interval = 1)
  ));  
end SumatriptanAndNaproxen;
